Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fibrinolysis Resistance in Infection and Trauma

NCT06680180 is registered in ClinicalTrials.gov with Anders Aneman as lead sponsor.

NCT NCT06680180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06680180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fibrinolysis Resistance in Infection and Trauma
Lead sponsor
Anders Aneman
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2024
Completion date
June 1, 2026
Enrollment
150 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis and septic shock, trauma